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ABSTRACT
Genome-scale engineering of living organisms
requires precise and economical methods to effi-
ciently modify many loci within chromosomes. One
such example is the directed integration of chem-
ically synthesized single-stranded deoxyribonucleic
acid (oligonucleotides) into the chromosome of
Escherichia coli during replication. Herein, we
present a general co-selection strategy in multiplex
genome engineering that yields highlymodified cells.
We demonstrate that disparate sites throughout the
genome can be easily modified simultaneously by
leveraging selectable markers within 500 kb of the
target sites. We apply this technique to the modifica-
tion of 80 sites in the E. coli genome.
INTRODUCTION
New capabilities that enhance the engineering of organisms
at the whole-genome scale provide avenues to construct
biological systems with new properties. Such engineering
can produce minimized (1) or mosaic (2) genomes, or ones
that may contain new genes, pathways, metabolisms and
fundamentally different regulatory structure (3). However,
these projects require signiﬁcant time and resources to
accomplish by traditional genetic engineering or lab-scale
evolution approaches. Prior work demonstrated that
targeted chromosomal modiﬁcations could be efﬁciently
introduced in Escherichia coli using synthetic oligonucleo-
tides (oligos) complementary to the lagging strand of the
replicating chromosome (4–6), which we refer to as
oligo-mediated -Red allelic replacement (AR). This type
of method has been used in other prokaryotic and eukary-
otic systems (7–9). Such an approach provides several
advantages: AR is an extremely general mechanism;
user-deﬁned oligos can target anywhere in the chromosome
without a need for site-speciﬁc nucleases; no antibiotic or
other functional selection is necessary and the mutagenesis
process leaves no sequence-based ‘scars’ in the genome.
Furthermore, oligo-mediated genome engineering can also
be multiplexed and automated (10).
We recently described multiplex automated genome
engineering (MAGE), using AR to combinatorially
modify 24 targeted sites throughout the genome, to
rapidly increase the output of a metabolic pathway (10).
We have also applied MAGE to the modiﬁcation of
hundreds of genome sites of E. coli MG1655 in pursuit
of a re-engineered genetic code (11). Herein, we present a
general co-selection (CoS) strategy based on MAGE to
isolate highly modiﬁed cells with many chromosomal
modiﬁcations. We demonstrate that one or more select-
able genetic markers (within 500 kb of the targeted sites)
can be used to obtain as many as eight targeted modiﬁca-
tions in a single MAGE cycle. We further iterate these
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cycles to accumulate many more modiﬁcations over a
1.1Mb span of the E. coli chromosome. This type of
CoS strategy can also be applied to incorporate multiple
new regulatory elements into the chromosome (12).
MATERIALS AND METHODS
Multiplex automated genome engineering
MAGE uses single-stranded oligos to modify the
deoxyribonucleic acid (DNA) sequence of many different
chromosomal sites in vivo, frequently applying multiple
oligos over several iterations (10). A singleplex, single cycle
of MAGE is comparable with the oligo recombineering
technique of Court and co-workers (4,6,13).
Allele switching and selection
MAGE was used to switch gene functions off and on
in vivo, using CoS oligos that either introduce (and
later remove) a stop codon or remove (and later
re-introduce) the translation start site. In multiplex experi-
ments, dilute quantities of these CoS oligos were used,
typically at 1% (each) of the total oligo concentration.
For example, we ﬁnd that a 10-plex cycle of MAGE is
maximized when using 0.5mM of each oligo (5 mM total)
and 0.05 mM of each CoS oligo. The selectable genes used
in this study are kan, bla, cat and tolC. The lacZ gene
was also used as a means to quantify and screen for
modiﬁed cells.
Media, chemicals and reagents
Liquid cultures of all strains were grown in LB-Lennox
media (referred to hereafter as LB) containing tryptone
(10 g/l), yeast extract (5 g/l) and NaCl (5 g/l) and
buffered to pH 7.45 with NaOH. Chloramphenicol (cat),
kanamycin (kan) or carbenicillin (carb) were added to LB
cultures or LB-agar plates (LB with 15 g agar/L) at con-
centrations of 20 mg/ml, 30 mg/ml or 50 mg/ml, respectively.
X-Gal (40 mg/ml) and isopropyl b-D-1-thiogalacto-
pyranoside (0.1mM) were used on LB agar plates for
functional assay of b-galactosidase activity. Multiplex
polymerase chain reaction (PCR) kits were purchased
from Qiagen (Cat no. 206143). Standard agarose gel elec-
trophoresis reagents were used. Colicin E1 was expressed
in strain JC411 and puriﬁed as described by Schwartz and
Helinski (14).
Primers and other oligos
All oligos were obtained from Integrated DNA
Technologies with no additional puriﬁcation. Oligos for
AR contained either two phosphorothioate linkages at
the 30 and 50 terminus or four phosphorothioate linkages
at the 50 terminus unless designated otherwise. We have
found that protection of the oligo with at minimum two
phosphorothioate linkages at the 50 terminus improves
MAGE efﬁciency by a factor of 2 (10).
Escherichia coli strains
Construction of EcNR1, EcNR2 and EcFI5 strains was
previously documented (10). In brief, our -Red construct
(including the ampicillin resistance gene bla) derived from
a defective temperature-inducible  was introduced by P1
transduction to E. coli MG1655 to produce EcNR1
(DbioA::l-Red-bla). EcNR2 is an EcNR1 derivative with
DmutS::cat. EcFI5 is an EcNR2 derivative with
DgalK::kan and made kanamycin and chloramphenicol
sensitive by inactivating the kan and cat gene using two
oligos kan_off and cat_off that introduced a nonsense
mutation in each gene to create the genotype
DgalK::kan(-) and DmutS::cat(-). EcBS2 is derived from
EcFI5 using oligo bla_off to deactivate the bla gene.
EcBS3 is derived from EcFI5 using oligo tolC_off to de-
activate the tolC gene. EcBS5 was derived from EcNR1 by
(i) switching the mutS gene into an inactive state using
MAGE and oligo mutS_off (Supplementary Table S4);
(ii) deleting the endogenous tolC gene and (iii) inserting
the tolC gene within the region to be modiﬁed, between
the yohC and yohD genes. (Experiments using other
strains than EcBS5 used the endogenous tolC marker.)
Colicin E1 expression strain JC411 was obtained from
Roberto Kolter.
Oligo-mediated AR
Allele-replacement-competent cells were generated as
described previously (10). In brief, individual colonies
from a freshly streaked overnight plate were inoculated
into 3ml LB aliquots and grown in a rotator drum at
300 rpm at 32C. On reaching OD600 of 0.7, the glass
tubes were moved to a 42C shaking water bath for
15min to induce the expression of -Red proteins. Cells
are then immediately chilled on ice for at least 5min and
subsequently made electrocompetent in 1 ml aliquots by
twice pelleting and resuspending in cold-sterile dH2O.
Cells are ﬁnally concentrated 20-fold into 50 ml dH2O
containing oligos. This 50 ml volume is electroporated
with a BioRad GenePulser (set to 1800V, 25 mF, 200 )
using a 1-mm gap cuvette. Electroporated reactions are
immediately added to 3ml of warm LB media and re-
covered for at least 3 h (to allow segregation of modiﬁed
alleles and division into clonal daughter cells) before
plating on LB-agar. A typical multiplex MAGE recom-
bination would use a total oligo concentration of 5mM
(i.e. 250 picomoles in the 50 ml electroporation volume).
Thus when using 10 non-selectable oligos, these would be
present at concentrations of 0.5mM each (25 picomoles
each in the 50 ml) and when using CoS, 0.05mM of each
CoS oligo was used (2.5 picomoles each in the 50 ml, i.e.
approximately 1% of the total oligo concentration).
Multiplex allele-speciﬁc colony PCR
Multiplex allele-speciﬁc colony PCR (MASC-PCR) as
described previously (11,15) was used to genotype sets of
clones to estimate allele replacement (AR) frequencies and
assess the distribution of modiﬁcations among groups of
clones. In short, two sets of primers were synthesized for
each genomic locus, one corresponding to the mutant
allele and one corresponding to the wild-type (WT)
allele. The forward primers were identical except at the
30 terminal nucleotide that corresponded to the speciﬁc
sequence of either the mutant or WT allele. The reverse
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primer was the same for both alleles. Primers were
designed for a target Tm of 62
C. To query the genotype
in a clone, the mutant and WT allele primer sets were run
in separate colony PCR reactions. A clone containing the
mutant allele will generate PCR products only using the
mutant allele primers and not the WT primers and vice
versa for a clone with the WT allele. Non-speciﬁc ampli-
ﬁcation of both mutant and WT primers were observed
when a suboptimal annealing temperature was used. A
gradient PCR was thus done to experimentally determine
the optimal annealing temperature, which tended to vary
from 62C to 67C depending on the primer sequence.
Multiple loci were queried in a single PCR reaction
using the multiplex PCR kit from Qiagen and pooled
primer sets that produced amplicons of length 100, 150,
200, 250, 300, 400, 500, 600, 700 and 850 bp, correspond-
ing to up to 10 different genomic loci. In each 20 ml PCR
reaction, 1 ml of a 1 in 100 dilution in water of a saturated
clonal culture (i.e. produced from a colony one wishes to
assay) generated the best MASC-PCR speciﬁcity. PCR
cycles were heat activation and cell lysis for 15min at
95C, denaturing for 30 s at 94C, annealing for 30 s at
the optimized annealing temperature, extension for 80 s
at 72C, repeated cycling for 26 times and ﬁnal extension
for 5min at 72C. Gel electrophoresis on a 1.5% agarose
gel produced the best separation for a 10-plex
MASC-PCR reaction.
Multiplex allele-speciﬁc colony quantitative PCR
To complement the MASC-PCR analyses, we also used a
highly multiplexed quantitative PCR (qPCR) screen to
rapidly identify clones that contained the highest degree
of modiﬁcation. This technique is reported in full detail
elsewhere (11). Two qPCR reactions were compared for
each clone evaluated, one with 10 or more pairs of primers
matched to the unmodiﬁed TAG genes and the other with
the same number of primer pairs matched to the intended
TAA modiﬁcations. The TAG reactions were expected to
proceed most efﬁciently with a WT template and the TAA
reactions most efﬁciently with a fully modiﬁed template.
Intermediate values between these extremes also provided
an effective, though non-linear gauge of the extent of
modiﬁcation for each clone.
Each colony was used as template for a pair of qPCR
reactions comparing the ampliﬁcation efﬁciency when
matched to primers terminating in WT or targeted
mutant sequence. The experimental measurement for a
given clone is then compared with the equivalent values
measured for the unmodiﬁed starting (negative control)
strain. This reference value is subtracted from each Cq
to yield a Cq, with unmodiﬁed clones scoring close to
zero (as with the negative control colonies). The largest
Cq values were expected to indicate the most modiﬁed
clones, which we conﬁrmed by genotyping clones with
varying Cq values. Large numbers of clones could be
quickly assessed with this approach (up to 191 per
384-well plate, plus a negative control). A typical assess-
ment of MAGE-cycled clones partitioned a 384-well plate
into 4 groups of 96 wells. Each group of 96 wells was thus
used to assay 48 colonies (44–46 queried colonies plus 2–4
control colonies) at 10 loci. After identiﬁcation of the most
promising clones, site-speciﬁc qPCR genotyping was used
to identify which speciﬁc sites had been modiﬁed, selecting
the best clones for further modiﬁcation.
Individual bacterial colonies were picked from LB-agar
plates by touching a 20ml pipette tip to a colony and
suspending this small amount of cells in 0.5ml sterile dis-
tilled deionized water; 5ml of this suspension was used as
template in 20ml qPCR reactions containing 1 NovaTaq
buffer, 0.5U NovaTaq Hotstart DNA Polymerase (EMD
Biosciences), 250mM each deoxynucleotide triphosphate
(dNTP), 0.5 SYBR Green I (Invitrogen) and 5%
dimethyl sulfoxide (DMSO). Primer concentrations were
50nM for each of 10 primer pairs, i.e. 500 nM total
forward primers and 500nM total reverse primers. A
typical qPCR program included a 10min hot start at
95C, followed by 40 cycles (95C for 30 s, 60C for 30 s
and 72C for 30 s) ﬁnishing with a melt curve analysis. All
reactions were performed in a 7900 HT system (Applied
Biosystems). PCR primers for all sites were designed to
have a melting temperature estimated at 62C. Reverse
primers were chosen to yield amplicons in the size range of
200–225 bp. No optimization was needed for qPCR primer
sequences or for multiplex/singleplex reaction conditions.
Allele frequency qPCR to determine AR frequencies
Allele frequency qPCR (AF-qPCR) was used to measure
AR frequencies throughout larger cell populations
produced by MAGE. This technique queries the ensemble
population of a cell culture instead of individual clones. The
method of Germer et al. (16) was modiﬁed to more accur-
ately quantify extreme high (>90%) and low (<10%)
frequencies (P.A.C., B.S. and J.M.J, in preparation). As
with MASC-PCR earlier, two pairs of primers are used,
matching either WT or mutant sequences to discriminate
between alleles.
AF-qPCR templates were either homogeneous cultures
grown in LB (positive and negative controls) or heteroge-
neous mixtures variable for two alleles, most frequently the
TAG WT and TAA mutant stop codons described
elsewhere (11). Each culture was used as template for a
pair of PCR reactions comparing the ampliﬁcation fre-
quency when matched to primers terminating in WT or
targeted mutant sequence. The difference in these two
frequencies (in ampliﬁcation threshold cycle, Cq) for a
control reaction deﬁnes the lower and upper (0% and
100%) limits of the measurement. The experimental meas-
urement for a mixed culture is then compared with these
reference values to calculate a percentage representation for
each allele in the pool. The AFmethod of Germer et al. (16)
was used as a starting point, with reﬁnements to the
calculation to more accurately determine high frequencies
(90–99%) and low frequencies (1–10%); 5 ml of cell culture
(typically diluted 1:100 or 1:1000 into dH2O) was used as
template in 20 ml qPCR reactions containing 1 NovaTaq
buffer, 0.5 U NovaTaq Hotstart DNA Polymerase (EMD
Biosciences), 250 mM each dNTP, 0.5 SYBR Green I
(Invitrogen) and 5% DMSO. Primer concentrations were
500 nM each. A typical qPCR program included a 10min
hot start at 95C, followed by 40 cycles (95C for 30 s, 60C
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for 30 s and 72C for 30 s) ﬁnishing with a melt curve
analysis. All reactions were performed in a 7900 HT
system (Applied Biosystems). PCR primers for all sites
were designed to have a melting temperature estimated at
62C. Reverse primers were chosen to yield amplicons in
the size range of 200–225 bp.
CoS singleplex experiments
Escherichia coli strain EcBS2 was subjected to a single
MAGE cycle to modify genes at 20 locations dispersed
throughout the genome. Each separate electroporation
was performed as a singleplex experiment, i.e. dominated
by the presence of one oligo with the intent to modify one
site. Trace amounts of three other oligos were included for
restoring function at selectable loci cat-, kan- and bla-.
Resultant cultures were grown under selective and
non-selective conditions, and the extent of modiﬁcation
at each target site was assessed by AF-qPCR. The
impact of CoS for these functions was calculated as a
CoS factor F=E(selection)/E(no selection).
Observing CoS synergies
AR frequencywasmeasured for oneMAGEcycle at a single
chromosomal site pphB ﬂanked by a pair of deactivated
selectable marker genes, tolC- and cat-. Contexts ranged
from singleplex (1 oligo, mole fraction=1) to highly multi-
plexed (24 different oligos, i.e. each atmole fraction=0.04).
The groupings of sites and their targeted mutations are
indicated in Supplementary Table S3. Trace amounts of
CoS oligos (1% of total) were included for restoring
selectable function. Resulting cultures were grown under
conditions selecting for re-activated proximal marker (cat,
<5 kbp), distal marker (tolC, >300 kbp), both and neither.
Multicycle CoS MAGE with alternating selections
Performing multiple cycles of CoSMAGE in series requires
either many markers that can each be selected once or a
single marker that can alternately be selected in the on and
off states. For addressing a set of 80 sites in the E. coli
chromosome, we used many cycles of CoS MAGE using
the dually selectable tolC gene. When the CoS oligo used
was tolC_on, the post-electroporation culture was allowed
to recover at 30C with agitation for 1 h before plating 80ml
on LB agar with carbenicillin and 0.005% sodium dodecyl
sulphate (SDS) to isolate tolC+ colonies. When the CoS
oligo used was tolC_off, the post-electroporation culture
was allowed to recover and grow at 30C with agitation
for no less than 5 h. This culture was then allowed to grow
to mid-log and OD600 of 0.4–0.6. At the same time, a
known tolC+ culture was brought to the same state of
growth to serve as a negative control. Each of these was
used to inoculate a tube of 2ml LB and 20ml colicin E1
preparation with 20ml cell growth. These cultures were
allowed to grow for 8–12h. Each was then plated (typically
100ml of a 105 dilution of mid-log culture or a 106
dilution of conﬂuent culture) onto LB agar with carbeni-
cillin to isolate colonies for screening. Strain EcBS5 was
used as the starting strain for this experiment. This strain
has the endogenous tolC gene seamlessly deleted and
re-inserted within the region to be modiﬁed (40 targets on
either side in the chromosome).
RESULTS
To efﬁciently modify genomes, we introduce several
distinct oligos into the cells simultaneously, which integrate
into actively replicating chromosomes at high frequency
(10). For any given site, the speciﬁc oligo anneals to the
lagging strand of the DNA replication fork, resolving into
one of the daughter cells (Figure 1) (17). Although each site
is modiﬁed by incorporating a unique oligo, we hypo-
thesized that oligos targeting multiple sites in close
proximity should integrate into the same newly synthesized
strand of the chromosome. When a daughter cell contain-
ing one such modiﬁcation is isolated by selection, we ex-
pect that this cell would be highly enriched for other
modiﬁcations at nearby sites in a co-operative manner, a
process we refer to as CoS (Figure 1). With this strategy,
selectable genes can be used as CoS markers in various
combinations across different regions of the genome to
enhance MAGE through CoS. These markers can be
pre-existing in the genome or inserted into the chromosome
Figure 1. Mechanism for MAGE AR with CoS. The dividing chromosome is schematized, with integration of a mutagenic oligo into the genome at
a replication fork [adapted from Costantino and Court (4)]. An oligo electroporated into the cell is bound by multiple copies of the  -bacteriophage
b protein and anneals to the lagging strand during DNA replication. When multiple oligos are incorporated into nearby sites (black and gray
rectangles), they are predicted to co-segregate at high frequency, often inherited by the same daughter cell. Thus, a permissive replication fork seems
to be a limiting factor in MAGE. Using one of these modiﬁcations to change the function of a selectable gene allows selection to remove
unmodiﬁed cells.
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by double-stranded DNA recombineering (8) and switched
on or off by oligo-mediated AR.
To characterize the effect of CoS on E. coli, we ﬁrst
measured single AR frequencies at 20 sites spaced around
the 4.6Mb chromosome (Figure 2A). Each of the oligos
used generated a single-basepair silent mutation (stop
codon TAG to TAA). These sites were drawn from a
larger group of 314 such targeted codon replacements
reported previously (11). In addition, three CoS marker
sites were chosen (two in close proximity to each other and
one on the opposite replichore). These markers are
inactivated bla (ampicillin/carbenicillin), kan (kanamycin)
and cat (chloramphenicol) resistance genes on the chromo-
some, each encoding a reversible nonsense mutation. We
used CoS oligos (bla_on, kan_on and cat_on) that can
restore the selectable phenotype to these markers. For
each of the 20 sites, a ‘singleplex’ MAGE experiment
targeted the modiﬁcation of one TAG site, while also
including more dilute amounts of CoS oligos for CoS.
Thus, each electroporation introduced one speciﬁc targeting
oligo (5mM concentration) plus the three CoS oligos
(0.05mM each). We then measured the resulting AR
frequencies with and without CoS.
CoS yielded notable enhancement of AR frequencies,
quantiﬁed as a CoS factor—the ratio of AR frequencies
with and without selection (Figure 2A). Consistent with
our hypothesis, we observed that CoS enhanced AR freque-
ncies especially at sites within 500kb of the selected CoS
markers on the same replichore. (We note that the rightmost
data point in Figure 2A appears to show a strong cat CoS
enhancement at a much greater distance. However, one of
the two unselected AR frequencies was quite high at this
locus, a potential outlier giving rise to the large error bar.)
Moreover, greater enhancements were observed at sites in
phase with the direction of the replication fork, i.e. ‘down-
stream’ of the CoS markers (farther from the origin of
replication).
To further investigate these proximity effects, we assessed
the effect of CoS with multiplex MAGE experiments using
24 target sites ﬂanked by two CoS markers. These sites
spanned a 320 kb region in the same replichore of the chro-
mosome, ﬂanked by inactivated CoS markers (cat- and
tolC-). We characterized the AR frequencies at multiple
sites, with and without CoS. Figure 2B shows AR
frequencies for one representative site (pphB) within 5 kb
of the cat- marker and more than 300kb from the tolC-
marker. CoS for conversion of the (cat-) marker proximal
to pphB produced a greater enhancement than CoS for con-
version of the (tolC-) marker distal to pphB. CoS for both
ﬂankingmarkers produced the greatest enhancement. These
effects are observed for both singleplex conditions (one site
modiﬁed, i.e. using one oligo plus CoS oligos) but are
greatest under highly multiplexed conditions (up to 24
distinct oligos plus CoS oligos, see also Supplementary
Figure S1 and Supplementary Table S3).
To explore the extent to which CoS can enhance
multiplexed genome engineering in greater detail, we
quantiﬁed the AR frequencies for 37 sites throughout the
chromosome. These sites were divided into four subsets
(A–D, Supplementary Table S2) in varying positions
relative to two CoS markers, cat- and kan-, located on
opposite replichores (Figure 3A). In Replichore 1, Group
A sites are clustered in close proximity to the kan- marker,
and Group B sites are more dispersed. In Replichore 2,
Group C sites are clustered in close proximity to the cat-
marker, and Group D sites are more dispersed. AR
frequencies for these targets were evaluated in up to
10-plex MASC-PCR reactions (Supplementary Methods).
This allowed us to both measure AR frequencies at individ-
ual sites (Figure 3B) and to assess the distributions of
modiﬁcations in the resulting clones (Figure 3C). The
frequencies of AR across the 37 target sites were measured
by screening up to 48 isolated clones under each CoS condi-
tion (none, kanamycin, chloramphenicol or both). The
Figure 2. (A) 20 sites were separately modiﬁed throughout the E. coli genome in singleplex MAGE experiments in the presence of CoS oligos that
re-activate the genes cat, kan and bla. Resultant cultures were grown under selective and non-selective conditions, and the AR frequencies at each
site were assessed by AF-qPCR. A CoS factor (the ratio of AR frequencies with and without CoS) is shown—factors greater than one indicate
increased frequencies due to CoS. (B) AR frequency was measured for one MAGE cycle at a single chromosomal site (pphB) ﬂanked by a pair of
deactivated CoS markers. Contexts ranged from singleplex (one oligo, 100%) to highly multiplexed (24 oligos, each 4% of the pool) not including
the CoS oligos. Resulting cultures were grown under conditions selecting for either re-activated proximal marker (cat, <5 kb), distal marker (tolC,
>300 kb), both and neither.
Nucleic Acids Research, 2012 5
 at M
IT Libraries on June 18, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
average AR frequencies for these experiments are given in
SupplementaryTable S1.When cells were not co-selected for
restoration of eitherkan- or cat-marker, theAR frequency in
the multiplexed reaction was low, averaging 3.7% per site.
Targets in close proximity to the co-selected markers on the
same replichore (Group A/kan and Group C/cat, <56kb)
showed the greatest frequency improvements under CoS—
giving average CoS factors from 3.3- to 5.5-fold. In contrast,
CoS at the opposite replichore (Group A/cat and Group
C/kan, >1.4Mb) yielded a modest improvement—CoS
factors of 1.3- to 1.6-fold. When frequencies are plotted
against the distance to the nearest CoS markers on the
same replichore (Figure 3B), we ﬁnd the greatest improve-
ments clustering near these markers.
To evaluate the synergistic effects among sites under
CoS, we further analyzed the distribution of conversions
accumulated for individual clones in Groups A–D
(Figure 3C, Supplementary Figure S4). Without CoS,
most of the population (70%) remained unmodiﬁed.
Cross-replichore CoS showed marginal increases in the fre-
quency at which mutants were found. In contrast,
same-replichore CoS dramatically increased the frequency
of mutants with large numbers of modiﬁcations. Double
CoS of one marker on each replichore further increased
multiplexed AR frequencies, giving rise to conversions in
70% of the cell population. These populations contained
individuals with as many as 8 of 10 targeted conversions
(Group A: six co-selected sites veriﬁed by MASC-PCR,
plus two marker sites by kan/cat double selection). These
results showed that a single cycle ofMAGE can operate in a
single cell at 8 or more spatially distinct loci.
We posit that CoS in general isolates cells that have
taken up more oligos, giving rise to the modest increases
in AR frequencies during cross-replichore CoS. Moreover,
proximity-based CoS (within 500 kb) especially increases
the likelihood of isolating cells which had chromosomes at
an optimal stage of replication for obtaining correlated
AR events. This effect is notable in our ability to easily
Figure 3. Co-selection enhances multiplex AR. (A) Diagram of four groups of targets A–D based on proximity to selectable loci kan (A, B) and cat
(C, D). Each group contained 8–10 targets, not counting CoS markers (Supplementary Table 2). Groups A (eight targets) and C (9 targets) are within
56 kb from kan and cat, respectively, whereas Groups B and D (10 targets each) are within 694 kb from kan and cat, respectively. (B) AR frequency
of Groups A–D mapped to distance to nearest selected locus, kan or cat, and the increased frequency for each site when CoS was applied.
(C) Frequency distribution of clones in the population with different numbers of additional conversions in each of four Groups A–D, under no
selection, cat, kan or cat/kan CoS. Same-replichore CoS is indicated in red lettering.
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isolate highly modiﬁed cells. Without CoS, the average
AR frequency across all sites of Groups A–D was
3.7(±3.4)% per target. With double CoS of the kan and
cat markers, the average was 15.6(±9.4)%, a 4-fold
improvement (Supplementary Figure S4). If these
co-selected frequencies were independent of each other,
the population of modiﬁed clones would be described by
a binomial distribution. For AR frequencies of 3.7%, only
one colony in 1.5 107 would contain six or more modi-
ﬁcations of eight (excluding the CoS markers), and we
would need to screen at least 4.5 107 clones for a 95%
likelihood of obtaining one (Figure 4; see later for detailed
calculations). Frequencies of 15.6%, would require 104
colonies to meet the same goal, a >4000-fold decrease in
the scale of colony screening. However, in the earlier
experiment, the 6-conversion mutant was found by
screening only 48 colonies with CoS.
We have consistently achieved this level of performance
in CoS experiments using from 6 to 24 different oligos,
yielding clones with 5–8 modiﬁcations (Figure 5) per
round of CoS-MAGE. We attribute our increased ability
to enrich for highly modiﬁed cells to co-operative effects
of CoS, isolating groups of sites that are converted
together. Using simple MASC-PCR or multiplex
allele-speciﬁc colony qPCR (MASC-qPCR) methods, we
can readily screen 100 or more colonies for conversion at
up to 12 target sites simultaneously with a turnaround
time of 3–4 h. Without CoS, one either needs to screen
or genotype an impractical number of clones, or expect
to perform many more cycles of MAGE (11,15).
Only a low concentration of the CoS oligos (relative to
total oligo concentration) is necessary to achieve CoS
enhancement (Supplementary Figure S2). A low CoS
oligo-to-total oligo ratio minimizes competition for
entry to the cell between the CoS oligo and the rest of
the oligo pool. However, a lower fraction of CoS oligo
leads to a smaller population of surviving cells as a result
of selection (i.e. fewer cells recombine a molecule of the
CoS oligo, so fewer cells survive selection). This bottle-
neck reduces the size of the population and diminishes
the diversity accessed using MAGE. Thus, for more
extreme dilutions of CoS oligos (0.01% of total or less,
or applying CoS at multiple CoS markers simultan-
eously), we have observed co-selected populations
dominated by small numbers of genotypes. A smaller
surviving population also produces a longer delay, as a
selected culture grows back to the required cell density
for the next MAGE cycle. We found that diluting the
fraction of CoS oligo to 0.1–1% of the total oligo pool
led most consistently to the greatest CoS enhancement
(Supplementary Figures S2, S3 and S4), without overly
restricting the cell population.
To illustrate how one might perform cycles of
CoS-MAGE in series, we used this strategy to recode
80 sites across one-fourth of the E. coli genome,
spanning 1.1 megabase pairs (Figure 5). A single dually
selectable tolC marker (11,18), inserted into the center of
this region, was repeatedly re-used for this purpose in
strain EcBS5. Odd cycles of co-selected MAGE
switched the tolC gene off by removing the start
codon, whereas even cycles reversed this change to
switch tolC on. At each cycle, up to 191 colonies were
screened by MASC-qPCR to identify highly modiﬁed
clones. Groups of 10 sites as identiﬁed previously (11)
were targeted for modiﬁcation with each pair of cycles.
Odd cycles included oligos to modify all 10 sites within a
group, whereas even cycles were used to ﬁnish off any
unmodiﬁed sites (from 2 to 6) of that group. Any sites
still left unmodiﬁed were then carried over, i.e. included
as targets for the following odd cycle. Thus for some
cycles, 11 or 12 conversions were attempted simultan-
eously (not including the CoS marker conversion). A
total of 18 cycles of CoS-MAGE were used (Figure 5).
All 80 sites were modiﬁed over the course of this experi-
ment, although one site (yegV, modiﬁed at cycle 2) was
modiﬁed back to WT inadvertently, being overwritten by
an overlapping oligo acting on another nearby site
(yegW, at cycle 8). Re-conversion of yegV to a TAA
stop codon was attempted again once (Figure 5, open
square at cycle 18) but was unsuccessful.
Cycles attempting the most modiﬁcations also yielded
the most modiﬁcations (Figure 5). For example, when
10–12 modiﬁcations were attempted, the results ranged
from 5 to 8 sites modiﬁed (with a mode of seven sites).
This outcome suggests that the most efﬁcient approach
to modifying a large group of sites would be to
maximize the number of sites addressed at every cycle
of the process. However, in experiments addressing as
Figure 4. Colony screening requirement to isolate clones with the
highest number of conversions based on a binomial model. AR
process is evaluated as a binomial process with each site being inde-
pendently converted. The solid lines correspond to relationship between
the number of clones needed to be screened from the population after
AR with oligos targeting eight sites and the highest number of conver-
sions that are expected to be found in one clone among the clones
screened. Each line corresponds to a different average per site AR fre-
quency. AR frequency of 3.7% and 15.6% are empirically determined
values for 37 sites with and without CoS, respectively. At a 95% con-
ﬁdence interval, the number of colonies needed to ﬁnd a 6-conversion
clone (indicated by the vertical gray dotted line) is shown as solid
circles. If 100 colonies are screened, one expects to ﬁnd 2- and
4-conversion clones for 3.7% and 15.4% AR efﬁciency, respectively
(solid squares and horizontal gray-dotted line). To ﬁnd a 6-conversion
clone by screening 100 colonies, we expect to need an average AR
frequency per site of 35% (solid triangle) assuming a binomial
process. In our experience, CoS yields a population of highly
modiﬁed clones that consistently outperforms expectations based on
independent AR frequencies.
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many as 20 sites (data not shown), we have not yet
observed more conversions than when addressing 12.
Strategies that allow the screening of many more
clones at many more sites are also likely to yield
more highly modiﬁed clones. For screening by
MASC-PCR or MASC-qPCR, multiplexing detection
up to 12 sites per PCR reaction well has been imple-
mented. Performing these techniques more intensively
would permit screening a few thousand clones per day
(e.g. 2-hour qPCR runs, 192 clones/run). If screening
limits were abolished, we anticipate even more
modiﬁed clones would be obtained. Other factors that
likely affect the reach of CoS-MAGE are the number of
oligo molecules entering the cell, the kinetics of oligo
survival in the cell and the rate of oligo incorporation
into the chromosome. Experiments to address these
factors are beginning to provide further improvement,
such as by limiting the action of endogenous nucleases
(J.A. Mosberg, C.J. Gregg, et al., in preparation).
In the earlier experiment, signiﬁcant time and effort was
required to produce and screen colonies at each cycle.
Although a cycle of MAGE normally can be performed
in 3 h or less as part of a larger automation process (10),
including CoS requires at least a similar amount of
additional time for growth under selective conditions.
Including screening at every cycle in the earlier example
then required plating cells to grow colonies, followed by
colony picking and PCR-based colony screening, extend-
ing cycle times to at least 2 days. The 80-site experiment
was paused at multiple intervals as convenient—thus 40-
day process was executed in approximately twice that
amount of time. The choice of frequent screening had
the beneﬁt of yielding the most highly modiﬁed clones to
pass to the next cycle. However, other applications of
CoS-MAGE will likely ﬁnd it most expedient to forgo
frequent screening and simply take advantage of the
strong enhancement provided by CoS, which can be
4-fold at each site (Supplementary Figures S2 and S3).
The latter approach would be especially preferred in
applications where one wishes to maximize the degree of
diversity generated in a modiﬁed population, such as for
optimizing a metabolic pathway (10) or tuning a genetic
circuit (12).
We developed a mathematical model to anticipate the
screening requirement when using MAGE to isolate
highly modiﬁed clones, both with and without CoS.
Modeling the multiplex AR as a simple binomial distribu-
tion with conversion events at each target site occurring
independently, we ﬁrst assume an average AR frequency
per site of p for a group of k sites. The abundance of
clones with n mutations in the population after a single
MAGE cycle is f=(k choose n) p n(1 p)k  n. To isolate
this n-mutation clone at a 95% likelihood needs to satisfy
the condition (1 f)s < 0.05. When solving for s, we get
Figure 5. Serial CoS-MAGE to address 80 genome sites. Repeated cycles of MAGE used CoS at a dually selectable tolC locus to reformat all
amber (TAG) stop codons spanning one-fourth of the E. coli MG1655 genome. Odd-numbered cycles switched tolC off and selected for the
absence of the gene product using colicin E1. Even-numbered cycles switched the tolC to an active state and selected for the presence of the
protein with SDS. After each cycle colonies were screened by MASC-qPCR to identify clones containing the largest number of successful edits.
One cycle (15) performed poorly (1 conversion of 12 attempted) due to arcing during electroporation. Left: Progressive editing of the genome is
shown for each cycle, with sites successfully modiﬁed shown with solid squares and those unmodiﬁed shown with open squares. Site locations
are indicated relative to the inserted tolC CoS marker. Right: Numbers of conversions at each cycle. The greatest number of conversions was
obtained for cycles attempting 10 or more (versus 6 or fewer). These yielded 5–8 conversions per cycle, with a median (and mode) of 7, not
counting the conversion of the CoS marker.
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s> log(0.05)/log(1 f), which is the number of colonies to
be isolated and screened to ﬁnd at least one clone with n or
more mutations at 95% likelihood (Figure 4). For k=8
and n=6 at p=0.037 (the AR frequency of 3.7%
without CoS observed above, Figure 3 and
Supplementary Table S1), we calculate s=44965 770.
At p=0.156 (AR frequency of 15.6% observed with
CoS in the same experiment), we ﬁnd that s=10420.
This calculation indicates that CoS-MAGE could reduce
screening requirements by >4000-fold under such
conditions. Furthermore, with CoS-MAGE, we observe
such highly modiﬁed clones at much higher frequencies
than this (e.g. 1 in 50 instead of 1 in 10 420 predicted).
Consistent with our physical model (Figure 1), these
results indicate that oligo incorporations into the same
region of the chromosome can be highly correlated and
not completely independent.
Examined another way, as we ﬁnd a 6-conversion
clone in our multiplex CoS experiment of eight target
sites at an abundance of 2% (f=0.02), this would only
be predicted by the above model if p=0.35 or 35%
(twice the observed value). At this AR frequency, we
need to screen 117 clones to conﬁdently ﬁnd a clone
with six conversions or more, which is on par with our
experimental ﬁndings. This analysis underscores two im-
portant points. First, a 4-fold improvement in AR fre-
quency per site translates to a dramatically decreased
screening need. Second, as the binomial model predicts
AR frequencies of 35% required to yield these
6-conversion clones (in sharp contrast to the 15.6% fre-
quency observed), the highly co-operative CoS process
does not seem to follow a simple binomial distribution
of independent events.
Another feature of CoS-MAGE is that it minimizes the
number of growth cycles cells must spend in a mutator
state. Performing MAGE at high efﬁciency typically has
relied on cells deﬁcient in mismatch repair, e.g. mutS- (4).
(Otherwise, the cell’s mismatch repair pathway attempts
to ‘repair’ the genome edits that are being attempted.)
However, performing MAGE this way also increases the
rate of accumulation of background mutations in the
genome (11). One strategy to avoid this limitation is to
leave the repair pathway intact and instead use oligo
sequences that create mismatches poorly recognized by
mismatch repair, such as CC mismatches (4), multiple
mismatches (17,19) and mismatches produced with
chemically modiﬁed bases (19). However, these
approaches place some sequence limitations on which
genome edits can be made.
When a genome engineering application requires
shutting off mismatch repair, the amount of cell growth
in the mutator state should be minimized. CoS-MAGE
provides a beneﬁt in this regard, requiring far fewer cycles
(and cell divisions) to reach a given objective. In addition,
we explored the possibility of turning mismatch repair off
temporarily at the beginning of MAGE cycling, so that it
could be turned back on when ﬁnished (Supplementary
Figure S5A). A mutS_off oligo was designed to edit the
ATG start codon of the mutS gene to ATC by creating a
CC mismatch poorly recognized by the mutS protein,
turning the gene off but not deleting it as in previous
studies (4). The mutS_off oligo was applied during the
ﬁrst cycle of a MAGE experiment where tolC on/off
switching was also used as described earlier. The popula-
tion fraction for the ATC (mutS_off) allele was measured
for four cycles of co-selected MAGE. We anticipated that
the mutS_off population would increase with each cycle,
even though the mutS_off oligo was only applied in the
ﬁrst cycle: CoS-MAGE selects at each cycle for cells that
have successfully taken up oligos and incorporated them
into their genomes, and only mutS_off cells should do
this (and survive) at high efﬁciency. We observed that the
mutS_off cells became dominant in the population after
only a few cycles of CoS-MAGE (Supplementary
Figure S5B).
We have observed the effects of CoS acting far from the
site of a given CoS marker and on both sides of the marker
(Figures 2A, 3B and 5). Nevertheless, an asymmetry was
observed, most prominently in Figure 2A (a singleplex
experiment) with CoS effectiveness dropping off sharply
for sites closer to the origin than the marker. Figures 3B
and 5 (multiplex experiments) may also indicate a measure
of this asymmetry, but if so, these effects are more modest.
The reason for this asymmetry—and why it might display
most prominently for singleplex experiments—is unclear.
Part of the explanation may lie in the nature of the
replicating arms of the chromosome, as the copy
number of genes (and thus numbers of targets for oligo
annealing) upstream of the marker will generally be
higher.
DISCUSSION
Currently, genomes can be engineered by different
complementary approaches including complete de novo
synthesis (20) and editing techniques such as MAGE
(10). De novo synthesis offers the ability to create new
genomes without a physical template but is limited by
the difﬁculty and cost of in vitro DNA assembly, by the
technical challenges of ‘booting’ a synthetic genome and
by the biological challenges of designing a highly
modiﬁed genome that will still support life. In
contrast, MAGE relies on the manipulation of an
existing genomic template in vivo to produce newly en-
gineered variants without the need for total re-synthesis.
Such template-mediated genome engineering is espe-
cially attractive in cases where the new constructs
share strong sequence similarity (>90%) with existing
constructs. As our approach modiﬁes an existing
genome by living intermediates, MAGE facilitates efﬁ-
cient incorporation of speciﬁed mutations and real-time
viability testing to identify and avoid any lethal muta-
tions. In contrast, de novo synthesis uses an
all-or-nothing synthesis and boot approach that does
not lend itself to easy troubleshooting. Furthermore,
template-based engineering can beneﬁt from natural se-
lection processes as new genomes progress by directed
steps from existing functional genomes.
We have previously reported the development of
hardware for efﬁcient automation of MAGE processes
(10). The selection steps of CoS MAGE can be easily
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incorporated into the cycles performed by this system for
obtaining the optimum combinations of modiﬁcation,
growth and selection. The CoS enhancement increases
the ability of MAGE to make very large numbers of
changes to a genome, especially when combined with
other tools such as conjugative assembly genome engin-
eering (CAGE) (11). As we previously reported using
MAGE and CAGE together to make 314 genome edits
in E. coli, CoS MAGE (with CAGE) provides the possi-
bility of extending this reach to thousands of sites. For
projects on a smaller scale, CoS can be used for a more
modest number of cycles performed manually (without
automation hardware) to modify dozens of sites (12).
CoS strategies dramatically increase our genome
engineering capabilities. We have demonstrated in
several experiments that CoS MAGE yields higher AR
frequencies, often improving by a factor of 4. This en-
hancement is especially useful when making many modi-
ﬁcations to a genome. For example, our recent report
altering stop codons in E. coli (11) required 18 cycles of
MAGE to produce an average of 8 modiﬁcations of 10
targeted sites. In contrast, with CoS-MAGE we now
easily isolate cells that incorporate an average of seven
modiﬁcations (plus one or two modiﬁed CoS marker
genes) after only a single cycle. Including CoS marker
conversions, we have demonstrated at least nine simul-
taneous modiﬁcations to the genome are possible. With
further tuning or screening more clones, a greater number
seems plausible. These increased frequencies are obtained
using easily switchable genetic markers to co-select for
several correlated AR events, targeting multiple chromo-
somal sites spanning as much as a megabase pair of a
genome (up to 500 kb from the selection gene in either
direction). Cells containing many such chromosomal
modiﬁcations can be isolated efﬁciently by screening
and can then be used for subsequent CoS-MAGE
cycles. Markers with both positive and negative selection
options (e.g. tolC, galK and thyA) are readily available
for this purpose. Deploying these markers throughout the
genome will generate programmable zones that are
hyper-responsive to genome engineering. With the
effects of CoS-MAGE spanning up to 1 megabase pair
per marker, only a modest number of markers may be
needed to fully address microbial genomes such as E. coli
MG1655 (4.6Mb).
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